Observation on the Efficacy of Montelukast in the Treatment of Children with Asthma and its Effect of TIMP-1 and MMP-9
- VernacularTitle:孟鲁司特联合常规治疗哮喘患儿的疗效及对血清金属蛋白酶-9及其抑制因子-1水平的影响
- Author:
Xiaomei WU
;
Liping LAN
- Publication Type:Journal Article
- Keywords:
Asthma;
Children;
Montelukast;
MMP-9;
TIMP-1
- From:
China Pharmacist
2016;19(7):1307-1308,1316
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the efficacy of montelukast in the treatment of children with asthma and its influence on the serum levels of metalloprotease-9 (MMP-9) and metal protease inhibitor-1 (TIMP-1).Methods:Totally 90 cases of asthma children were selected and divided into the control group and the observation group with 45 ones in each .The control group was treated with the conventional symptomatic treatment , and the observation group was treated with montelukast chewable tablets additionally , and the treatment course was 8w.The effectiveness adverse reactions were compared between the groups , and the lung function indices and the changes of MMP-9 and TIMP-1 levels of the two groups were compared as well .Results: The total effective rate of the observation group (93.33%) was significantly better than that of the control group (P<0.05).After the treatment, the levels of FEV1 and PEF were significantly higher than those before the treatment in the two groups , the levels of MMP-9 and TIMP-1 were notably lower than those before the treatment in both groups , and the changes in the observation group were more significant than those in the control group (P<0.05).There were no adverse drug reactions in both groups .Conclusion:Montelukast combined with the conventional therapy can down-regulate the serum levels of MMP-9 and TIMP-1 and inhibit airway remodeling resulting in improved curative effect with high safety.
